Diamond Hill Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
57,247
-516,693
-90% -$12.1M 0.01% 177
2026
Q1
$8.04M Buy
573,940
+64,238
+13% +$865K 0.05% 135
2025
Q4
$5.72M Buy
509,702
+75,041
+17% +$859K 0.03% 148
2025
Q3
$5.02M Buy
434,661
+89,630
+26% +$1.05M 0.02% 148
2025
Q2
$4.22M Buy
345,031
+149,667
+77% +$1.88M 0.02% 144
2025
Q1
$2.8M Buy
+195,364
New +$3.05M 0.01% 150

Other funds holding AVNS

Diamond Hill Capital Management's AVNS Position: Q2 2026 in Review

Diamond Hill Capital Management reduced its Avanos Medical (AVNS) stake by 90% in Q2 2026, selling an estimated $12.1M and leaving 57,247 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #177.

Diamond Hill Capital Management first reported a position in AVNS in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.04M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Diamond Hill Capital Management held 57,247 shares of Avanos Medical worth $1.42M as of Q2 2026.
  • Diamond Hill Capital Management sold 516,693 Avanos Medical shares in Q2 2026, an estimated $12.1M.
  • Avanos Medical made up 0.01% of Diamond Hill Capital Management's portfolio in Q2 2026, its #177 holding.
  • Diamond Hill Capital Management first reported a position in Avanos Medical in Q1 2025 and has held it in 6 quarters since.
  • Diamond Hill Capital Management's Avanos Medical position peaked at $8.04M in Q1 2026.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.